PMET Resources (PMET) Q2 2027 earnings summary

Executive summary

• Six-month net loss was C$4.522M versus C$2.382M; cash and cash equivalents were C$168.921M at September 30, 2026.

• Enhanced CV5 Feasibility Study targets ~C$5.1B after-tax NPV8% and ~40.4% IRR; Shaakichiuwaanaan’s updated resource includes 113.9 Mt indicated and 33.8 Mt inferred lithium resources.

Financial highlights

• Q2 FY27 net loss was C$2.416M versus C$0.706M in Q2 FY26; six-month net loss was C$4.522M versus C$2.382M.

• Six-month G&A expenses rose to C$12.993M from C$9.817M; C$5.384M of share-based compensation was recognized in profit or loss.

• Six-month deferred tax expense was C$4.712M and non-cash; Q2 flow-through premium income was C$6.4M and interest income was C$1.3M.

• Six-month operating cash use was C$9.688M versus C$7.036M; working capital was C$156.4M excluding the flow-through premium liability.

Outlook and guidance

• Targeting a CV5+CV13 PEA in late 2026 to assess integrated lithium, tantalum and caesium development.

• Permitting and community engagement are advancing toward FID by end-2027, subject to approvals and funding; project financing work is planned through 2026–2027.

• Bulk-sample permitting and funding are intended to support Nova Zone understanding and product validation; downstream discussions target future offtake and strategic partnerships.